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Adjuvant arthritis is a unique experimental disorder in which rats develop a 
migratory  polyarthritis  and  certain  other  tissue  lesions  about  10  to  14  days 
after a  single inoculation  of standard  Freund's  water-in-off adjuvant,  or some 
slight  variant  of it  (1,  2).  As  investigations  of  this  inducible  disorder  have 
proceeded,  it has  become fairly apparent  that  the  condition  is  caused  by an 
immunologic response on the  part of the inoculated host, although  the mecha- 
nisms responsible for this are as yet unclear.  One chief roadblock,  the elimina- 
tion  of an infectious  bacterial,  mycotic,  or mycoplasmal etiology, seemed un- 
likely when  a  culturable  microbiological  agent  could  not  be found  with  any 
consistency in either the inflammatory joint tissues or the serum, nor in fact in 
other  tissues  or  organs  (3).  Special  methods  for  isolating  mycoplasmal  or 
pleuropneumonia-like organisms from the arthritic lesions did not indicate that 
these  agents  were  involved.  Moreover,  adjuvant  arthritis  was  readily  repro- 
ducible in "germ-free" animals  (4), although  the presence of viruses could not 
be completely ruled out, even in this experiment. 
It was postulated  (5)  that  the  disease  was a  generalized  immunologic response, 
probably of the delayed or cellular type, to one or more antigenic constituents in the 
tubercle  bacillus,  since these  were essential ingredients  of the adjuvant.  The sensi- 
tizing antigen was probably not tuberculoprotein  since in the past 4 years we have 
used the wax D  fraction extracted from the human Canetti strain of tubercle bacilli, 
instead  of whole acid-fast  bacilli  in  the  adjuvant  mixture,  and  have had  equal  or 
somewhat  greater  success  in  inducing  arthritic  disease  with  this  preparation;  i.e., 
in 85 to 100 per cent or animals in various experiments. Furthermore a lack of paral- 
lelism has been noted, in animals inoculated with whole tubercle bacilli in adjuvant, 
between adjuvant arthritis and cutaneous tuberculin sensitivity (6).  Since the wax D 
fraction,  which is chemically classified as a  peptidoglycolipid  (or a  macromolecular 
glycolipid)  (7),  usually contains  a  minimal amount of protein,  it is not likely that 
the latter is the sensitizing agent,  although its  actual content  does vary somewhat 
* This study was supported by a grant from United States Public Health Service, (Grant 
A-1286). 
547 548  PASSIVE TRANSFER  OF  ADJIIVANT ARTHIZITIS 
from one preparation to another. One wax D  preparation, especially purified by Dr. 
Lederer, contained so little protein (if any at all) that it did not induce a tuberculin 
reaction in guinea pigs injected 3 weeks previously. Yet this preparation very suc- 
cessfuUy induced adjuvant arthritis. 
In  earlier experiments,  it was not possible to  transmit  the  disease when  either 
sizable amounts of acute phase or convalescent serum  (up to  15  ml, intravenously) 
was transferred from arthritic rats to normal recipients. Furthermore, transfer of the 
disease process was not previously successful when living sensitized lymph node cells 
were passed from donors sensitized with adjuvant containing whole acid-fast bacilli 
to non-inbred recipients even though some of the recipients were previously given 
whole body irradiation or had been rendered tolerant to specific donor cells (5). 
It  has  now  been  possible to  transfer  the  arthritic  disease passively from 
sensitized donors  to  normal  recipients  under  certain  conditions,  namely  (a) 
use of viable lymph node or spleen cells, (b) utilization of a highly inbred strain 
of rats,  (c) harvesting of cells from donors during certain time intervals after 
adjuvant injection into them, and (d) transfer of sufficient numbers of sensitized 
viable cells from either the lymph nodes or the spleen, but not from the thymus. 
These results constitute strong evidence that  adjuvant  arthritis is an immu- 
nological disease which is manifested through  a  delayed type of reaction, or 
some variant of it. In this respect, it can be aligned with experimental allergic 
encephalomyelitis, experimental allergic thyroiditis, allergic nephritis, and sim- 
ilar conditions, each of which has now been transmitted by sensitized lymph- 
oidal cells  (8-11).  Adjuvant  arthritis  differs  from  each  of  these  conditions, 
however, since in the latter one or more tissue antigens are added to the initial 
adjuvant inoculum,  whereas  none is incorporated prior to injection into  our 
rats. Hence, the identity of the responsible antigen in adjuvant arthritis is still 
llB.known. 
Methods 
All of the rats used in these experiments were of the highly inbred Lewis strain, and were 
obtained from Microbiological Associates, Bethesda. Rats of this strain have been used suc- 
cessfully in other transfer experiments  and were said to be unable to reject reciprocal skin 
grafts, although we did not conduct this test. All were healthy females, weighing 150 to 200 
gm at the start of the experiment.  The animals were kept in roomy cages in groups of six to 
eight per cage and donors were separated from recipients after they had been given adjuvant 
inoculations.  All were fed on Purina lab chow and water ad libitum, and clean conditions were 
maintained at all times, The adjuvant which was inoculated into donors was composed o 
4 parts by volume of a light mineral oil, one part emulsifier (Falba), and 3.2 parts saline to 
which was added the wax D fraction of the human Canetti strain of the tubercle bacillus  1 
in an amount of 1.0 mg/ml of final adjuvant. In order to provide better dispersion of the wax D 
fraction, it was mixed thoroughly with a small amount of 70 per cent alcohol  (usually 0.1 
to 0.2 ml to 28 mg of wax) immediately before mixing and emulsifying with the fluid contents 
of the adjuvant. 
1 Kindly  supplied  by Dr. E. Lederer, Laboratoire de Chimie Biologique, Facult6 des Sciences 
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All inoculations into donors were given, as in previously reported experiments (1, 2) into 
the skin of the superscapular area in multiple small deposit sites, the total amounting to about 
0.4 ml in all. In addition, 0.1  to 0.2  ml was administered into one or two foot-pads of some 
animals. Lymphoidal cells for passive transfer were obtained from the donors in various ex- 
periments on from the 4th to the 16th postinoculation days. Cells from the axJllary, olecranon, 
submaxillary,  superficial and  deep cervical and  inguinal nodes were harvested  and  pooled 
from several donors (usually 4 to 6 in number). Nodes especially chosen were those in prox- 
imity to adjuvant depots and those which could be rapidly extirpated and readily cleaned so 
that  they  could be rapidly  processed.  These procedures  assured  the harvesting  of ample 
numbers of viable cells. Spleen cells and thymus cells were each pooled separately from multi- 
ple donors. The residue or debris which remained after straining out the cells from any of the 
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organ structures  was pooled, along with some viable and  many dead cells,  resuspended in 
saline, and listed as "sediment." 
The  cell  suspensions  were  obtained  as  follows: Lymphoid  tissues  were  removed  from 
living donor rats under ether anesthesia, using antiseptic treatment  (70 per cent alcohol)  of 
instruments and the animal's shaved skin before incision. All other apparatus and glassware 
coming in contact with the excised tissues and the solutions were autoclaved. As fast as tissues 
were removed from the rat they were placed in a small Petri dish in cooled Hanks' balanced 
salt solution (HBSS), (12). These were refrigerated immediately at 40C until sufficient  tissues 
were accumulated  for one set of recipient rats.  They were then  teased apart  rapidly with 
fine forceps in fresh HBSS and pressed gently through a wire sieve (30 apertures per square 
inch) with a  metal spoonula to remove the connective tissue and large pieces which might 
clog the cytosieve (13). The unstrained debris was stored in a covered Petri dish at 4°C for 
later intraperitoneal  inoculation  while the  strained  material  was  put  through  a  modified 
cytosieve and then transferred to a centrifuge tube. HBSS was added to make 12 ml and it 550  PASSIVE TRANSFER  OF AD~IUVANT ARTHRITIS 
was centrifuged 10 minutes at  1800 R~. The buffy coat layer was pipetted off into a  fresh 
centrifuge tube having a  conical bottom, HBSS added to the 12 ml mark, and after gentle 
mixing with a  pipette,  centrifuged at  1400  RPM for 6  minutes. The white cells were again 
carefully pipetted off into another tube and enough HBSS added to a total volume of 2 or 3 
ml. This was the inoculum. It was injected immediately into the recipient animals in a  tail 
vein or  otherwise while another operator counted the number of  viable leucocytes in the 
suspension. The inoculation was given usually over a period of 3 to 10 minutes. Tests for the 
viability of harvested cells were made using the eosin Y dye exclusion test (12) on an aliquot 
of each pool.  Another aliquot was used for cell counting in the standard white blood cell 
counting chamber. 
All recipients were healthy and in the natural state.  Splenectomy, irradiation, or other 
procedure was not carried out beforehand. Each recipient received a specific number of viable 
cells from either lymph node, spleen, or thymic source. The general outline of the experimental 
design for many of the experiments is diagramatically illustrated in Text-fig. 1. Occasionally 
both intravenous and intraperitoneal inoculations were made. The thick sediment was always 
given intraperitoneally. A  few  recipients were  also given an intracutaneous inoculation of 
adjuvant on or close to the same day on which the cells were transferred. As a control fresh 
kidney tissue was pooled from 6  animals on the  llth postadjuvant day, minced in HBSS, 
and injected intraperitoneaUy into three recipients. Other investigators (14) have inoculated 
heat-killed lymphocytes from mycobacterial adjuvant-injected donors into recipients of this 
same inbred strain of rats. 
In all, donor lymphoid, spleen, or thymus cells were transferred from 70 sensitized donors 
to 28 recipient rats. Five recipients died within a few minutes of the intravenous injection of 
cells. These were omitted from the series. 
RESULTS 
An inflammatory polyarthritis  was passively transferred from adjuvant- 
injected or "sensitized"  Lewis rats  to untreated rats,  also  of that strain,  in a 
total of 12 out of 23 recipients.  These figures  probably do not represent the 
actual incidence  that could have been achieved, since  as various factors  were 
altered  according to information learned  from early  pilot  experiments, it was 
possible to transfer the disease in later experiments to 5/5 recipients which re- 
ceived more than 2.0 X  108 sensitized viable lymphoid or spleen cells. 
Careful adjustment of three factors appeared to be necessary for the success- 
ful transfer of arthritis. These included (a) the use of at least a certain minimal 
number of viable lymphoid cells,  (b) proper selection of the route of adminis- 
tration, and (c) selection of a proper time interval after adjuvant injection in 
the donor before harvesting the sensitized cells. 
In the initial pilot experiments,  sensitized cells from nodes and spleen were 
removed  on the  10th postadjuvant day and pooled before  injection.  In  this 
experiment,  0.36 to 1.56  X  108 cells were injected into each of six recipients. 
None developed arthritis. Subsequently, it was found that the minimum num- 
ber of viable cells necessary for transfer was 2.0 to 2.3 X  10  s if these were ob- 
tained from pooling of cells from lymph nodes from various areas of the body. 
However,  in  one  experiment  where  cells  were  taken primarily  from  the  en- 
larged  olecranon  nodes,  after  injection  of  the  adjuvant  into  the  forepaws, CARL M. PEARSON  AND  :FAE D. WOOD  551 
arthritis  was transferred with  1.70  X  l0  s cells, the smallest number that suc- 
cessfully  transferred  the  arthritis.  The  least  number  of  splenic  cells  which 
induced  arthritis  was  2.70  ×  108. On  the  other hand,  it  was  not possible  to 
transfer disease with cells obtained from the thymus gland.  Hence, in several 
trials  (total of four recipients)  from 4.95  X  10  s to 1.19  )<  109 thymocytes did 
not produce any visible disease in the recipients.  Thymocytes did not, on the 
other  hand,  seem  to have  an  inhibitory  effect  since  one  recipient  which  re- 
ceived a total of 1.12 X  109 mixed node and thymic cells intravenously, as well 
as  receiving  some  residual  node  and  thymic  gland  debris  intraperitoneally, 
TABLE I 
Cellular Transfer of Adjuvant A rthritis. Significance of Stage of Donor Preparation 
and Number of Cells Transferred 
Day 
Source of cells  after 
I adjuvant 
5 
7 
8 
8 
9 
10 
10 
10 
11 
11 
11 
11 
14 
Nodes and spleen ..................... 
Nodes and spleen ..................... 
Nodes and spleen ..................... 
Nodes and thymus .................... 
Nodes and thymus .................... 
Nodes .......................  ........ 
Spleen ............................... 
Spleen ............................... 
Nodes and thymus .................... 
Nodes ............................... 
Spleen ............................... 
Thymus ............................ 
Nodes or thymus or spleen ............. 
No. of cells 
transferred X  10  s* 
0.36; 1.91 
1.22 
1.52 
2.81 
11.20; 42.63 
1.70; 2.20 
1.78 
1.78 
0.39 
3.82; 8.05 
2.70; 3.83; 3.83 
11.96; 11.96 
2.10 to 4.95 
Arthritis in 
recipients 
No, 0/2 
No, 0/1 
No, 0/1 
No, 0/1 
Yes, 2/2 
Yes, 2/2 
Yes, 1/1 
No, 0/1 
No, 0/1 
Yes, 2/2 
Yes, 3/3 
No, 0/2 
No, 0/4 
* Cells given intravenously  to each recipient. 
developed significant polyarthritis  7 days later.  A  summation  of most of the 
transfer experiments is given in Table I. 
The intravenous route for administration of cells to recipients seemed to be by 
far the most satisfactory method and was used in nearly all of the experiments. 
When intraperitoneal or subcutaneous routes were used solely in five recipients, 
no disease developed despite the number of cells injected or their source, except 
in one animal which showed a  minimal  swelling  of one heel for 6  days after 
intraperitoneal injection of 4.26 X  109 mixed node and thymic cells. Six addi- 
tional animals  which received  an intracutaneous  injection  of adjuvant  on or 
within 1 or 2 days of the time of transfer of sensitized donor cells did not differ 
materially in their ability to develop arthritis,  either in intensity or time, from 
those which only received the cell suspension. Because of the complexities that 552  PASSIVE  TRANSFER  OF  ADJUVANT ARTHRITIS 
could arise from inclusion of these animals  in the final evaluation they were 
excluded from further consideration in the series. 
Although sufficient studies have not been  conducted in order  to draw un- 
equivocal  conclusions about this point, the impression has been  gained that 
TABLE II 
Transfer of Adjuvant Arthritis by Cells Obtained  from Rats Sensitized 10 and 11 Days Previously 
Experiment 
1-63-J-N 
Donors  Recipients 
I  days 
1  10  A.  Nodes and  3.8~  i.v.  Yes  5  4/10  22 
sediment,~  i.p. 
1.5 ml 
10  Ceils har-  B.  Spleen and  2.7£  i.v. '  Yes  3  5/14  15 
vested on  sediment,:~  i.p. 
day 11  1.5 ml 
11  C.  Thymus  1.9~  i.v.  No  -- 
10  D.  Thymus  1.9(  i.p.  No  -- 
10  E.  Sediment,  --  i.p.  No  -- 
4.0 ml 
Experiment 
3-63-B 
6 
7 
8 
9 
10 
11 
10  F. 
10  Cells har-  G. 
10  vested on  H. 
10  day 10  I. 
10 
Nodes (olec-  1.78[ i.v.  Yes  3  3/5§  -- 
ranon)  2.20 
Nodes  i.v.  Yes  3  2/5§- 
Spleen  1.78  i.v.  Yes  4  1/2  6 
Spleen  1.781 i.v.  No 
* Maximum score is 20 for the severest degree of arthritis (1). 
Sediment  =  debris remaining after removal of viable ceils  from nodes, spleen, and 
thymus. 
§ These recipients were sacrificed on day 5 for histological study. 
there  is  a  critical  time  period  after  adjuvant,  during which  lymph node  or 
spleen cells have the capacity to transfer arthritis to normal recipients. Hence, 
cells for all of the successful transfer experiments were obtained between days 
9 and 11, during which time a  polyarthritis was just developing in the donors. 
Two representative experiments are detailed in Table II where it will be noted 
that an arthritis of mild or moderate degree had already  developed in 5/5 and CARL  M.  PEARSON  AND  :FAE D. WOOD  553 
5/6 donor animals I or 2 days previously. Earlier transfer experiments made on 
days 5,  6,  8,  or 9 were unsuccessful but these experiments were parts of the 
early study when less than  1.56  X  10  s cells were given to each recipient. On 
the other hand, in one later experiment, ample numbers of lymph node, spleen, 
or thymus cells were harvested on day 14 from five donor rats and were given 
intravenously or intraperitoneally to four recipients. None of them developed 
disease (Table HI). It is interesting to note in the donor animals that the lymph 
TABLE III 
Failure of Transfer of Adjuvant Arthritis by Cells Obtained  from Rats Sensitized 
14 Days Previously 
Donors 
Rat  No. 
Experiment 
1-63-J-o 
6 
9 
10 
i 
11 
11 
10 
10 
10 
Sever- 
ity 
score* 
on day 
14 
10 
12 
Cells§ har- 
vested on 
day 14 
Rat 
No. 
F° 
G. 
H. 
Recipients 
I. 
Source of cells 
Nodes and sedi- 
ment,~ 0.8 ml 
Spleen and sedi- 
ment,~; 1.5 ml 
Thymus and sed- 
iment, 1.5 ml 
Sediment, 4.0 ml 
No. of 
viable 
cells 
x to  8 
2.10 
2.90 
4.95 
Route 
of in- 
jection 
i.v° 
i.p. 
i.V° 
i.p. 
i.v. 
i.p. 
i.p. 
Arth- 
ritis 
No 
No 
No 
No 
* Maximum score possible is 20 for the severest degree of arthritis. 
Sediment  =  debris remaining after removal of viable cells from nodes, spleen, and 
thymus. 
§ Nodes reduced in size, flabby, with nodular pearly hard centers. Thymuses average size 
or small. Spleens enlarged and containing white granulomas. 
nodes and thymus gland were small, flabby, and appeared to be fibrotic and 
depleted of many of their cellular constituents.  By the time that  the lymph 
node and other cells were harvested from these five donor animals, all of them 
had developed a  florid and severe polyarthritis.  It seems quite possible that 
most of the sensitized cells had by this time been released to the joint tissues 
where they were involved in the inflammatory articular disease. 
By contrast,  the lymph nodes removed for cell harvesting on days 8 to 11 
were enlarged and often quite firm. This was especially the case with the axillary 
and cervical nodes when adjuvant had been given into the skin of the super- 
scapular region,  or with  the homolateral olecranon and axillary nodes  when 554  PASSIVE  TRANSFER  OF  ADJUVANT  ARTttRITIS 
adjuvant was given into a forepaw. The olecranon nodes were often enlarged 
two to three times their normal size, and were usually pink and quite firm. A 
few contained small white spots, suggestive of adjuvant deposition. As some of 
these nodes were dissected, small droplets of oil, obviously embolized adjuvant, 
floated out. As much as possible of this material was removed by repeated 
washing and gentle centrifugation. 
The  spleens  of  donors  were  slightly enlarged  and  moderately congested. 
Occasionally one or more greyish-white spots 0.5 to 2.0 mm in diameter were 
present  in  the  subcapsular  zone.  This  was  especially notable  in  spleens  of 
14-day donors. Histologically, these were small reactive granulomas surround- 
ing embolized adjuvant material. The thymuses varied considerably in size. 
In general, those that were removed on the 7th to 10th postadjuvant inocula- 
tion days were somewhat enlarged, pink, and sometimes contained a few hem- 
orrhagic spots. On the 12th and 15th days, the thymuses were either normal in 
size or smaller than normal. 
In Lewis rats, as in other strains previously studied, injection of adjuvant was 
invariably followed by a 9 to 12 day latency period prior to the onset of poly- 
arthritis. In several hundred animals, the disease has never occurred before the 
9th day and usually does not appear until the llth or 12th day (Text-fig. 2). 
These  observations are  of special importance since  onset of the  transferred 
disease usually occurred on the 3rd to 6th days after inoculation of sensitized 
cells (Text-fig. 2). In the 12 recipients which developed lesions, 7 did so on day 
3 or 4, 1 on day 2, and 4 on days 5, 6, 7, and 8 respectively (over-all average, 
4.3 days). 
The lesions which developed in the recipients were identical in the gross in 
type and form to those observed after adjuvant inoculation (1,  2)  but gen- 
erally they were not as severe or extensive (Text-fig. 2). Based upon a rating 
system of 20 for over-all maximum arthritis  (1),  15 adjuvant-injected Lewis 
control animals had an average maximal score of 7.7 whereas the transferred 
arthritis in 12 animals had an average maximal score of 2.3. Also, the actively 
induced arthritis was of longer duration than the transferred disease. 
Periarticular swelling and erythema developed in the passively sensitized 
animals over the metacarpal phalangeal, metatarsal phalangeal, and proximal 
interphalangeal joints (Fig.  1),  along the tarsal bones, about the ankles and 
wrists, and occasionally in the tail between the caudal vertebrae.  Cutaneous 
and subcutaneous erythematous nodules also appeared on the dorsum of either 
hind- or forepaws (Fig. 2), on the tail, or along the course of the vessels in the 
ears (Fig. 3). All of these findings are similar to those which have been noted in 
animals actively sensitized with adjuvant, (1,  2,  15),  although in the latter, 
the lesions were more extensive and the periarticular swelling and erythema 
were usually much more marked. 
Histologically, the fully developed lesions were also similar to or identical CARL  M.  PEARSON  AND  FAE  D.  WOOD  555 
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with those observed in actively sensitized rats (16, 17). The passively induced 
lesions consisted of (a) inflammatory synovitis and subsynovial edema (Figs. 4 
and 5), (b) proliferation of connective tissue elements in focal areas in the sub- 
synovium, subcutaneous regions  of the paws and  ears,  peritendonous zones, 
and periosteum, (c) periosteal new bone formation, (d) some early granulation 
tissue  (pannus)  formation in  a  few animals,  and  (e) inflammation  and  con- 
nective tissue reactions adjacent to the intervertebral discs between the verte- 
brae  of the tail  (Fig.  6).  The inflammatory cellular  dements  consisted pre- 
dominantly  of  pleomorphic  mononuclears,  many  of  which  resembled  large 
lymphocytes or histiocytes (Fig. 7). Interspersed were also a few small lympho- 
cytes and occasional plasma cells or neutrophils. Some inflammatory loci were 
clustered in  the  immediate  subsynovial regions  as  shown in  Figs.  4  and  5. 
Usually large numbers of proliferative connective tissue elements resembling 
primitive fibroblasts were interspersed in and about these inflammatory cells. 
The histology of the subcutaneous nodules in the external ears was identical 
with that described in active adjuvant arthritis  (16,  17). It consisted of peri- 
vascular  (perivenous) accumulations of mononuclears,  some localized  edema, 
hyperemia, and occasionally  acanthosis of the adjacent epidermis  with micro- 
abscess formation. 
The histology of the passively transferred arthritis  has  only been studied 
from the  time  of clinical  recognition  of lesions  through  the  20th  day after 
its clinical appearance. In the latter case, a moderate degree of continuing in- 
flammation and connective tissue activity was present. It is likely that cellular 
invasion begins several hours or 1 or 2 days before it becomes clinically evident, 
but we have no evidence on this point. Furthermore, the limits of persistence 
of the gross  or microscopic disease  following  a  single  injection  of sensitized 
ceils, or repeated administration of them, is not known at this time. 
DISCUSSION 
Adjuvant arthritis  has been considered to be an immunologically Luduced 
disease,  but most of the evidence in this respect has been indirect. Thus,  the 
latency period of approximately I0 days after adjuvant injection, the positive 
correlation between the severity of the reaction at the local injection site and 
the subsequent development of arthritis,  the ability to induce immune toler- 
ance-like  phenomena,  and the inhibitory effects of whole body irradiation  and 
corticosteroids (2, 18) all favor this conclusion  and the inability to culture an 
infectious agent (3, 19) has removed from active consideration another etiologi- 
cal  possibility.  The  strongest  evidence so far  adduced for  an  immunologic 
etiology of adjuvant arthritis is the passive transfer of this condition as reported 
herein. 
Very recently Waksman and Wennersten  (14) have also described success CARL M. PEARSON  AND  leAE D. WOOD  557 
in passive  transfer of adjuvant  arthritis  in  rats  using essentially the  same 
technique and in fact the same Lewis strain of inbred rats, except that they 
splenectomized nearly all donor rats 3 to 4 weeks prior to use for transfer of 
cells.  We did not find this maneuver to be necessary, although it may have 
been  responsible  for  the  somewhat  more  severe  passive  disease  which  de- 
veloped in Waksman and Wennersten's animals. The latency period of 2  to 
8 days, average, 4.3 days in our series, is much shorter than the average (11.3 
days) in a large series of actively sensitized animals of either the Lewis strain 
or others with which we have dealt. Negative controls in our series consisted of 
animals injected with (a)  sensitized cells  disrupted by repeated freezing and 
thawing, (b) "debris" composed of a few viable and many non-viable cells and 
stroma from either nodes, spleen,  or thymus, or  (c)  homogenates of kidney 
tissue.  Waksman and Wennersten could not passively transfer disease after 
gentle heating of suspensions of sensitized cells or by transfer of control cells 
from donors injected with oil alone. These results point to the specificity of 
the reaction and the need for viable lymphoid cells,  thus indicating the ira, 
munologic character of adjuvant arthritis. 
Of added interest were two other points. The first was that, although not 
proven  conclusively, it  appeared  that  lymph node or spleen  cells  were  not 
competent  to  transfer  the  disease  until  approximately  the  8th  day  after 
adjuvant  injection.  Thereafter,  sufficient  numbers  of  sensitized  cells  were 
present in these tissues only until about the 11th postadjuvant day after which 
the nodes and, to a  lesser degree, the spleen appeared to have released large 
numbers of cells which probably localized in and about the joints and produced 
the clinical disease. The nodes at this time were small, flabby, and obviously 
much less  replete with cells  than they were several days previously. On the 
14th postadjuvant day, it was not possible to transfer a  clinical disease, even 
when large numbers of cells were pooled and transferred. Presumably by this 
time most or all of sensitized cells had been discharged from these tissues and 
the cells which were harvested were either a fresh non-sensitized crop or were 
comprised chiefly of stromal and other non-sensitized types. A second interesting 
observation was that cells obtained from the thymus gland did not have the 
capacity to transfer adjuvant arthritis regardless of when after adjuvant in- 
jection they were obtained. 
The clinically recognizable passively transferred lesions which are produced 
in and about the joints and in the subcutaneous tissues are similar in all respects, 
except perhaps in severity, to those noted in classical adjuvant arthritis. Prob- 
ably the ability to develop such detectable lesions is related both to the time 
after adjuvant injection when the donor ceils are harvested, and the number of 
sensitized cells  which are given. It is likely, although as yet unproved, that 
even small numbers of ceils can produce histologically detectable lesions in and 558  PASSIVE TRANSFER OF AD~tYVANT ARTHRITIS 
about joints and adjacent tissues, whereas larger numbers of sensitized cells 
or repeated injection of such ceils given at appropriately spaced intervals could 
cause a much more severe or a chronic and perpetuated disease. 
The localization of lesions in the synovium and adjacent connective tissue, 
and in the subcutaneous regions of certain parts of the body signifies  that a 
degree of tissue specificity exists in the sensitized cells. Visceral organs rarely 
contain any lesions or cellular collections in actively sensitized animals, except 
for occasional granulomas in the lung and spleen in some animals (1).  None 
were observed in the passively sensitized recipients who developed arthritis. 
Is the small amount of adjuvant which must have been unavoidably trans- 
ferred along with the node or spleen cells sufficient to induce an active arthritis 
in the recipient animals? It probably is not for the following reasons: (a) it is 
known that a minimal quantity of about 0.04 ml of adjuvant containing tubercle 
products is required in order to induce active disease (20).  It is not possible 
that such an amount would be transferred in the repeatedly washed cell suspen- 
sions,  since  although some adjuvant is  known to reach regional nodes and 
spleen soon after inoculation (20) and some also migrates to the paws and lungs, 
the great majority (probably 50 to 70 per cent) remains for several days or 
weeks in the local injection site; (b)  the appearance of arthritis 3 or 4  days 
after cell transfer renders any kind of actively induced arthritis most uulikely, 
since regardless of the adjuvant dose, whether it be large or small, or the route 
of administration, it has never been possible to induce active disease sooner 
than 9 days after inoculation. 
The  two pressing  questions that  this study does not answer concern the 
nature of the antigen and the precise mechanisms involved in the development 
of the disease process.  Since adjuvant arthritis can now be considered with 
reasonable assurance to be caused by some type of immunological reaction, a 
more directive effort can be made to answer these questions. 
An  adjuvant-induced arthritis  has  been passively transferred in  a  highly 
inbred strain of rats by transfer of viable lymph node or spleen cells, but not 
thymus cells,  to normal recipients. After an interval averaging 4.3  days re- 
cipients developed arthritis, whereas animals actively sensitized with adjuvant 
never developed disease before the 9th day (average  11.3  days). The trans- 
ferred disease had all of the gross and pathological characteristics of primary 
disease,  except  for  a  lesser  severity.  Control studies  using  non-viable  cells 
either of lymphoidal or other tissue origin were always negative. It is concluded 
that adjuvant arthritis is the result of an immunologic reaction which is perhaps 
similar to delayed hypersensitivity. The antigen in this reaction so far remains 
obscure. CARL M. PEARSON AND  FAE D. WOOD  559 
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EXPLANATION OF PLATES 
PLATE 42 
FIG.  1.  Passively  transferred  arthritis  in  both  forepaws  as  seen  I0  days  after 
transfer of lymph node cells. Onset of arthritis occurred in the 4th post-transfer day. 
Adjuvant was also given to this animal on the day the cells were inoculated. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 120  PLATE  42 
(Pearson and Wood: Passive transfer of adjuvant arthritis) PLATE 43 
FIG. 2.  Passively induced arthritis 4 days after transfer of 4.52  X  108 lymphoid 
cells. Note diffuse and mottled swelling of left hindpaw and 2 or 3 small erythematous 
areas on the right paw. THE  JOURNAL OF  EXPERIMENTAL MEDICINE  VOL.  120  PLATE  43 
(Pearson and Wood: Passive transfer of adjuvant arthritis) PLATE 44 
FIG. 3.  A group of five erythematous perivascular lesions are seen in the external 
ear in this animal 7 days after receipt of large numbers of lymph node, spleen, and 
thymus cells. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 120  PLATE  44 
(Pearson and Wood: Passive transfer of adjuvant arthritis) PLATE 45 
FIG. 4.  Recipient 10 days after transfer of sensitized cells and 6 days after onset of 
arthritis.  Metatarsal  joint showing intense  inflammation,  edema,  synovial prolifera- 
tion, and an immediate subsynovial cellular collection.  Hematoxylin and eosin.  ×  162 THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL  120  PLATE  45 
(Pearson and Wood: Passive transfer of adjuvant arthritis) PLATE 46 
FIG. ,5.  Recipient as in Fig. 4. Tarsal joint showing cellular reaction and vascular 
congestion in a fibrous villus and adjacent synovium. Hematoxylin and eosin.  X  162. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 120  PLATE 46 
(Pearson and Wood: Passive transfer of adjuvant arthritis) PLATE  47 
Fie,.  6.  Recipient  as  in  Fig.  4.  Tail.  Intense  inflammation  adjacent  to  a  caudal 
intervertebral disc. Hematoxylin and eosin.  ×  50. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  120  PLATE 47 
(Pearson and Wood: Passive transfer of adjuvant arthritis) PLATE 48 
FIG.  7.  Recipient as  in  Fig. 4.  Higher magnification to illustrate the  types of in- 
flammatory  cells  which  are  involved  in  the  reactive  response.  Hematoxylin  and 
eosin.  X  410. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL.  120  PLATE 48 
(Pearson and Wood: Passive transfer of adjuvant arthritis) 